NCT02907437 Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia Status UNKNOWN Phase PHASE3
NCT02905604 Magnetic Stimulation of the Brain in Schizophrenia or Depression Status COMPLETED Phase NA
NCT02901587 Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder Status COMPLETED Phase PHASE1
NCT02901015 Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients Functioning Status COMPLETED Phase NA
NCT02897167 Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients Status COMPLETED Phase N/A
NCT02896374 Normal and Abnormal ERP During ToM and Emotional Conflicts in Schizophrenia Status COMPLETED Phase NA
NCT02892422 Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT02880995 [18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis Status UNKNOWN Phase NA
NCT02880462 A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia Status COMPLETED Phase PHASE2
NCT02879604 Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia Status COMPLETED Phase NA
NCT02876900 Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia. Status COMPLETED Phase PHASE3